Who Owns PJP?

Invesco Pharmaceuticals ETF — Institutional Ownership & 13F Holdings

$103.90

-0.08 (-0.08%)

Market Cap

$311.4M

Shares Outstanding

2,941,082

Institutional Holders

95

Total Inst. Value

$333.4M

% of Float Held

QoQ Holder Change

+28

Institutional data as of Q1 2025

New Positions

18

Closed Positions

9

Increased

20

Decreased

22

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO$282.0M3,256
2Peak Asset Management, LLC$11.5M132,817
3MORGAN STANLEY$4.0M46,057
4BANK OF AMERICA CORP /DE/$3.7M43,072
5UBS Group AG$3.1M36,188
6Federation des caisses Desjardins du Quebec$2.4M27,892
7WELLS FARGO & COMPANY/MN$2.4M27,141
8MGB Wealth Management, LLCNew$1.8M21,142
9Joseph Group Capital Management$1.7M19,335
10DUMONT & BLAKE INVESTMENT ADVISORS LLCNew$1.7M19,241

Biggest Buyers & Sellers This Quarter

Related Stocks

Frequently Asked Questions

How many institutional investors hold PJP?

As of Q1 2025, 95 institutional investors report holding PJP (Invesco Pharmaceuticals ETF) in their 13F filings.

Which hedge fund owns the most PJP?

The largest institutional holder of PJP is NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO with $282.0M in shares.

Are institutions buying or selling PJP?

This quarter, 18 institutions opened new positions in PJP and 9 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.